Bloomberg: Intrivo CEO on CareStart™ EUA approvals
August 12, 2020
![](https://cdn.prod.website-files.com/60c0c07083a2a0662f48d0be/66609103ff88b64e46235593_60c0d91f875a6c151f037205_CEO-EUA-approvals.jpeg)
You might also like
Reeve Benaron, chairman and interim chief executive officer at Intrivo, discusses the U.S. Food and Drug Administration’s emergency use authorization of a Covid-19 antigen test the company distributes for Access Bio. Benaron speaks with Bloomberg’s Emily Chang. (Source: Bloomberg)